BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12792733)

  • 21. Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer.
    Montiel-Equihua CA; Martín-Duque P; de la Vieja A; Quintanilla M; Burnet J; Vassaux G; Lemoine NR
    Cancer Gene Ther; 2008 Jul; 15(7):465-73. PubMed ID: 18421306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery.
    Cho JY; Xing S; Liu X; Buckwalter TL; Hwa L; Sferra TJ; Chiu IM; Jhiang SM
    Gene Ther; 2000 May; 7(9):740-9. PubMed ID: 10822300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
    Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
    J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
    Haberkorn U; Kinscherf R; Kissel M; Kübler W; Mahmut M; Sieger S; Eisenhut M; Peschke P; Altmann A
    Gene Ther; 2003 May; 10(9):774-80. PubMed ID: 12704416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-expressing adenoviral vectors encoding the sodium iodide symporter for use in noninvasive radiological imaging of therapeutic gene transfer.
    Niu G; Anderson RD; Madsen MT; Graham MM; Oberley LW; Domann FE
    Nucl Med Biol; 2006 Apr; 33(3):391-8. PubMed ID: 16631088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS.
    Wenzel A; Upadhyay G; Schmitt TL; Loos U
    Mol Cell Endocrinol; 2003 Dec; 213(1):99-108. PubMed ID: 15062578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the sodium/iodide symporter by retinoids--a review.
    Schmutzler C
    Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
    Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
    Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction.
    Wagner S; Aust G; Schott M; Scherbaum WA; Feldkamp J; Seissler J
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):398-402. PubMed ID: 12518250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
    Jung KH; Paik JY; Ko BH; Lee KH
    J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line.
    Cheng W; Fu H; Feng F; Ma C; Li J; Chen S; Wang H
    Nucl Med Biol; 2013 May; 40(4):576-80. PubMed ID: 23618770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.